MPR Weekly Dose

MPR Weekly Dose 125 — Device Cleared to Treat C-Section Pain; Plaque Psoriasis Cream; Contrast Agent Shortage Addressed; Lucentis Biosimilar Approved; OTC Laxative Recall Expanded

MPR Weekly Dose 125 — Device Cleared to Treat C-Section Pain; Plaque Psoriasis Cream; Contrast Agent Shortage Addressed; Lucentis Biosimilar Approved; OTC Laxative Recall Expanded

A neurostimulation device has been cleared for post-C-section pain; a new plaque psoriasis treatment; the FDA address the contrast agent shortage; Lucentis biosimilar treatment is approved; and the recall for an over-the-counter laxative is expanded.

Duration: 11 min

Release Date:

Share part or all of the audio of this episode